Big Win for HP&M Client: Court of Appeals Tells FDA to Regulate Barium Sulfate As a Device
FDA Law
APRIL 19, 2021
Genus Medical Technologies secured an important victory in the D.C. In Genus Medical Technologies v. FDA , the Court of Appeals ruled that FDA cannot regulate a medical product – in this case, the radiographic contrast agent barium sulfate – as a drug when the product meets the definition of a device.
Let's personalize your content